Tromsø eye study: Prevalence and risk factors of diabetic retinopathy

Acta Ophthalmologica

Volumn 91, Issue 8, 2013, Pages 716-721

  Bertelsen, Geir ^a   Peto, Tunde ^b   Lindekleiv, Haakon ^a   Schirmer, Henrik ^a   Solbu, Marit D ^c   Toft, Ingrid ^a,c   Sjølie, Anne Katrin ^a,d   Njølstad, Inger ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

diabetic retinopathy; epidemiology; microalbuminuria; prevalence; risk factors

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RETINA IMAGE; RETINA MACULA EDEMA; RISK ASSESSMENT; RISK FACTOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

DIABETIC RETINOPATHY; EPIDEMIOLOGY; MICROALBUMINURIA; PREVALENCE; RISK FACTORS;

AGED; AGED, 80 AND OVER; CHOLESTEROL; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NORWAY; PREVALENCE; QUESTIONNAIRES; REGISTRIES; RISK FACTORS; VISUAL ACUITY;

EID: 84888180466     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02542.x     Document Type: Article

References (33)

1. Arnlov J, Evans JC, Meigs JB, et al., (2005): Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112: 969-975.
2. Bertelsen G, Erke MG, Hanno TV, et al., (2003): The Tromsø Eye Study: study design, methodology and results on visual acuity and refractive errors. Acta Ophthalmol, Epub ahead of print.
3. Brown JB, Pedula KL, &, Summers KH, (2003): Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care, Epub ahead of print.
4. Buch H, Vinding T, &, Nielsen NV, (2001): Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology 108: 2347-2357.
5. Buch H, Vinding T, La Cour M, Appleyard M, Jensen GB, &, Nielsen NV, (2004): Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology 111: 53-61.
6. Cheung N, &, Wong TY, (2008): Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 27: 161-176.
7. Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, &, Wong TY, (2007): Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke 38: 398-401.
8. Cikamatana L, Mitchell P, Rochtchina E, Foran S, &, Wang JJ, (2007): Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye 21: 564-471.
9. Danaei G, Finucane MM, Lu Y, et al., (2011): National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: 31-40.
10. DCCT Research Group (1995): Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 102: 647-661.
11. DCCT/EDIC Research Group (2002): Effect of intensive therapy on the microvascular complications of Type 1 diabetes mellitus. JAMA 287: 2563-2569.
12. Emanuele N, Sacks J, Klein R, Reda D, Anderson R, Duckworth W, &, Abraira C, (2005): Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care 28: 1954-1958.
13. Gunnlaugsdottir E, Halldorsdottir S, Klein R, et al., (2011): Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-R). Diabetologia 55: 671-680.
14. Hillege HL, Fidler V, Diercks GF, et al., (2002): Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782.
15. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, &, Njølstad I, (2011): Cohort profile: the Tromsø Study. Int J Epidemiol, Epub ahead of print.
16. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, &, Dawber TR, (1977): The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 106: 17-32.
17. Kilstad HN, Sjølie AK, Gøransson L, et al., (2011): Prevalence of diabetic retinopathy in Norway: report from a screening study. Acta Ophthalmol, Epub ahead of print.
18. Klein R, &, Klein BEK, (2010): Are individuals with diabetes seeing better? Diabetes 59: 1853-1860.
19. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1984): The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532.
20. Kramer CK, Rodrigues TC, Canani LH, Gross JL, &, Azevedo MJ, (2011): Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both Type 1 and 2 diabetes. Diabetes Care 34: 1238-1244.
21. Mitchell P, Smith W, Wang JJ, &, Attebo K, (1998): Prevalence of diabetic retinopathy in an older community: the blue mountains eye study. Ophthalmology 105: 406-411.
22. Rema M, Srivastava BK, Anitha B, Deepa R, &, Mohan V, (2006): Association of serum lipids with diabetic retinopathy in urban South Indians-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2. Diabet Med 23: 1029-1036.
23. Saaddine JB, Honeycutt AA, Narayan KMV, Zhang X, Klein R, &, Boyle JP, (2008): Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol 126: 1740-1747.
24. Solbu MD, Kronborg J, Jenssen TG, et al., (2009): Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis 204: 503-508.
25. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR, & Group ft (2001): UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44: 156-163.
26. UKPDS (1998): Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
27. Varma R, Macias GL, Torres M, Klein R, Pena FY, &, Azen SP, (2007): Biologic risk factors associated with diabetic retinopathy the Los Angeles Latino Eye Study. Ophthalmology 114: 1332-1340.
28. Wild S, Roglic G, Green A, Sicree R, &, King H, (2004): Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
29. Wilkinson CP, Ferris FL III, Klein RE, et al., (2003): Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110: 1677-1682.
30. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, &, Girach A, (2004): Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18: 963-983.
31. Wong TY, Cheung N, Tay WT, et al., (2008): Prevalence and risk factors for diabetic retinopathy: The Singapore Malay Eye Study. Ophthalmology 115: 1869-1875.
32. Xu J, Wei WB, Yuan MX, et al., (2011): Prevalence and risk factors for diabetic retinopathy: The Beijing Communities Diabetes Study 6. Retina 32: 322-329.
33. Zhang X, Saaddine JB, Chou C-F, et al., (2010): Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 304: 649-656.